These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 34487603

  • 1. Protective efficacy of Alum adjuvanted Amidase protein vaccine against Staphylococcus aureus infection in multiple mouse models.
    Suresh MK, Vasudevan AK, Biswas L, Biswas R.
    J Appl Microbiol; 2022 Feb; 132(2):1422-1434. PubMed ID: 34487603
    [Abstract] [Full Text] [Related]

  • 2. Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice.
    Ghaedi T, Davoodian P, Hassaniazad M, Eftekhar E, Faezi S, Abparvar AA, Einakian MA, Ahmadi K.
    J Immunol Methods; 2021 Jul; 494():113055. PubMed ID: 33857474
    [Abstract] [Full Text] [Related]

  • 3. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M, Haghighat S, Mousavi Z, Abdolghaffari AH, Yazdi MH.
    Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
    [Abstract] [Full Text] [Related]

  • 4. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.
    mBio; 2016 Feb 02; 7(1):e02232-15. PubMed ID: 26838725
    [Abstract] [Full Text] [Related]

  • 5. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

  • 6. Cloning, expression and purification of autolysin from methicillin-resistant Staphylococcus aureus: potency and challenge study in Balb/c mice.
    Haghighat S, Siadat SD, Sorkhabadi SM, Sepahi AA, Mahdavi M.
    Mol Immunol; 2017 Feb 30; 82():10-18. PubMed ID: 28006655
    [Abstract] [Full Text] [Related]

  • 7. A novel recombinant vaccine candidate comprising PBP2a and autolysin against Methicillin Resistant Staphylococcus aureus confers protection in the experimental mice.
    Haghighat S, Siadat SD, Sorkhabadi SMR, Sepahi AA, Mahdavi M.
    Mol Immunol; 2017 Nov 30; 91():1-7. PubMed ID: 28858628
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amidase, a cell wall hydrolase, elicits protective immunity against Staphylococcus aureus and S. epidermidis.
    Nair N, Vinod V, Suresh MK, Vijayrajratnam S, Biswas L, Peethambaran R, Vasudevan AK, Biswas R.
    Int J Biol Macromol; 2015 Nov 30; 77():314-21. PubMed ID: 25841371
    [Abstract] [Full Text] [Related]

  • 10. Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
    Chan JYH, Clow F, Pearson V, Langley RJ, Fraser JD, Radcliff FJ.
    Immunol Cell Biol; 2024 Nov 30; 102(5):365-380. PubMed ID: 38572664
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to Staphylococcus aureus.
    Roy Chowdhury R, Fitch RW, Ghosh SK.
    Vaccine; 2013 Feb 06; 31(8):1178-86. PubMed ID: 23313815
    [Abstract] [Full Text] [Related]

  • 12. Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice.
    Mortazavi SS, Haghighat S, Mahdavi M.
    Microb Pathog; 2020 Mar 06; 140():103945. PubMed ID: 31874228
    [Abstract] [Full Text] [Related]

  • 13. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Galletti B, Laera D, Pallaoro M, Tuscano G, Fontana MR, Bensi G, Grandi G, Rossi-Paccani S, Nuti S, Rappuoli R, De Gregorio E, Bagnoli F, Soldaini E, Bertholet S.
    PLoS One; 2016 Mar 06; 11(1):e0147767. PubMed ID: 26812180
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI, Anjum AA, Ijaz M, Hussain R, Ahmed R, Farooqi SH, Aslam HB, Hussain K, Mehmood K, Zhang H.
    Microb Pathog; 2018 Apr 06; 117():341-347. PubMed ID: 29510207
    [Abstract] [Full Text] [Related]

  • 15. Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models.
    Ohsawa H, Baba T, Enami J, Hiramatsu K.
    Microbiol Immunol; 2015 Apr 06; 59(4):183-92. PubMed ID: 25659598
    [Abstract] [Full Text] [Related]

  • 16. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
    Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS.
    Infect Immun; 2006 Apr 06; 74(4):2215-23. PubMed ID: 16552052
    [Abstract] [Full Text] [Related]

  • 17. Clearance of Staphylococcus aureus from In Vivo Models of Chronic Infection by Immunization Requires Both Planktonic and Biofilm Antigens.
    Harro JM, Achermann Y, Freiberg JA, Allison DL, Brao KJ, Marinos DP, Sanjari S, Leid JG, Shirtliff ME.
    Infect Immun; 2019 Dec 17; 88(1):. PubMed ID: 31712267
    [Abstract] [Full Text] [Related]

  • 18. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP, Thompson CD, Aman MJ, Lee JC.
    Vaccine; 2016 Dec 07; 34(50):6402-6407. PubMed ID: 27847174
    [Abstract] [Full Text] [Related]

  • 19. Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus.
    Glowalla E, Tosetti B, Krönke M, Krut O.
    Infect Immun; 2009 Jul 07; 77(7):2719-29. PubMed ID: 19364833
    [Abstract] [Full Text] [Related]

  • 20. Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus.
    Ranjbariyan A, Haghighat S, Yazdi MH, Arbabi Bidgoli S.
    World J Microbiol Biotechnol; 2022 Nov 19; 39(1):16. PubMed ID: 36401129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.